Related Experiment Video
Updated: Jul 20, 2026

A Tactile Automated Passive-Finger Stimulator (TAPS)
Published on: June 3, 2009
A call to action
1Department of Pathological Biochemistry, Glasgow Royal Infirmary, Scotland, U.K.
Insights
Acute myocardial infarction (AMI) is a leading cause of death. Implementing lifestyle changes and managing blood pressure and lipid profiles can reduce cardiovascular risk, but physician adoption of guidelines remains slow.
Area of Science:
- Cardiology
- Preventive Medicine
- Public Health
Background:
- Acute myocardial infarction (AMI) remains a primary cause of mortality in individuals over 40.
- Despite observed reductions in coronary heart disease (CHD) mortality, significant potential exists for further decrease.
- Cardiovascular morbidity and mortality can be reduced through lifestyle interventions and control of hypertension and dyslipidemia.
Purpose of the Study:
- To emphasize the need for multifactorial approaches in cardiovascular disease (CVD) prevention.
- To highlight the gap between established clinical guidelines and their implementation by physicians.
- To advocate for the integration of lipid-lowering therapy in CHD prevention strategies.
Main Methods:
- Review of existing guidelines for primary and secondary CHD prevention.
- Analysis of survey data on physician practices regarding risk factor management.
- Emphasis on the role of lifestyle interventions, blood pressure control, and lipid management.
Main Results:
- Physicians have been slow to adopt and implement CHD prevention guidelines.
- Routine measurement of serum cholesterol concentrations is inadequate.
- Hypercholesterolemia is frequently undertreated, despite the availability of effective lipid-lowering agents.
Conclusions:
- A multifactorial approach is essential for effective CVD risk reduction.
- Physicians must improve adherence to clinical guidelines for CHD prevention.
- Lipid-lowering therapy should be considered a cornerstone of both primary and secondary CHD prevention.
Abstract:
Acute myocardial infarction remains the principal cause of death in people aged over 40 years, despite the reductions in coronary heart disease (CHD) mortality that have been observed over the past 25 years in many European countries. Consequently, there is considerable potential to decrease further the risk of cardiovascular morbidity and mortality. This can be achieved through effective lifestyle interventions and appropriate control of blood pressure and blood lipid profiles. Such a multifactorial approach to treatment is warranted because of the complex, and often synergistic relationships between independent risk factors, such as smoking and lipid levels. Guidelines have been introduced to facilitate the application of effective primary and secondary CHD prevention programmes that target multiple risk factors, according to the risk factor profile of the individual. However, it is apparent from recent surveys that physicians have been slow to adopt and implement these guidelines in clinical practice. The extent to which serum cholesterol concentrations are routinely measured is especially poor, and even when hypercholesterolaemia is identified it is frequently undertreated. Since effective lipid-lowering agents are now available and should provide substantial benefits in terms of CHD risk reductions, physicians are urged to consider lipid-lowering therapy as an essential component of both primary and secondary CHD prevention programmes.
More Related Videos
Related Concept Videos
Contact-dependent Signaling
Gap Junctions
In animal cells, gap junctions are formed...
Persuasion Strategies
Intracellular Signaling Affects Focal Adhesions
Some...
Tension Response at Adherens Junctions
α-Catenin as a Mechanosensory Protein
The α-catenin of adherens junctions is an allosteric protein with three VH (vinculin homology) domains...
T Cell Activation and Clonal Selection
Naive T cells that have not yet encountered an antigen express two primary CD...
Impression Management Techniques III: Aligning Actions

